B2DB — Who said what, where, and when

Thomas P. Garner

Principal Scientist (Biophysics), Genentech

Thomas P. Garner is listed as Principal Scientist (Biophysics), Genentech. Thomas spoke at Drug Discovery Chemistry Europe 2026 in November 2026 (speaker, “Measuring Stable Interactions by SPR: Addressing the Long Residence-Time Challenge”). Speaks mainly at Hospitals and Health Care events.

Compiled from published conference agendas; not yet confirmed by Thomas. Is this you? Claim this profile.

About

Thomas Garner joined Genentech in 2020. He is a Principal Scientist in the Biochemical and Cellular Pharmacology (BCP) department. Thomas is the BCP and biophysics representative on several key pipeline projects at Genentech, developing SPR and other biophysics assays to facilitate hit finding and hit-to-lead development at Genentech. Thomas earned his MSci. in Biochemistry and Biological Chemistry at the University of Nottingham in the United Kingdom. Thomas continued his studies at the University of Nottingham to earn a PhD in the Biological Chemistry Department, with a focus on NMR-based structural biology and biophysics of protein-protein and DNA-drug interactions. In 2010, he moved to the United States as a postdoctoral fellow at Louisiana State University. In 2012, he joined the Gavathiotis lab at the Albert Einstein College of Medicine (AECOM). While at AECOM, he studied the regulation and inhibition of Bcl-2 family proteins and became faculty in 2017.

Sessions at 1 conference

Drug Discovery Chemistry Europe 2026 11 November 2026 – 12 November 2026

Others from Genentech

See all 7 speakers from Genentech